Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;39(2):718-26.
doi: 10.1007/s10753-015-0298-7.

Enolase of Streptococcus Suis Serotype 2 Enhances Blood-Brain Barrier Permeability by Inducing IL-8 Release

Affiliations

Enolase of Streptococcus Suis Serotype 2 Enhances Blood-Brain Barrier Permeability by Inducing IL-8 Release

Yingying Sun et al. Inflammation. 2016 Apr.

Abstract

Streptococcus suis serotype 2 (SS2) is an emerging zoonosis, and meningitis is the most frequent clinical manifestation, but mechanism of its virulent factor, enolase (Eno), is unknown in meningitis. In this study, Eno was inducibly expressed and added to an in vitro Transwell co-culture model of the blood-brain barrier (BBB) consisted of porcine brain microvascular endothelial cells (PBMECs) and astrocytes (ACs), the results showed that Eno induces a significant increase in BBB permeability and promotes the release of IL-8 et al. cytokines. Furthermore, IL-8 could significantly destroy the integrity of the BBB model in vitro. In mice models administered Eno for 24 h, Eno could significantly promote Evans blue (EB) moving from the blood to the brain and significantly increased the serum and brain levels of IL-8, as detected by ELISA. While G31P (IL-8 receptor antagonist) significantly decreased the concentration of EB in the brains of mice injected with Eno. The present study demonstrated that SS2 Eno may play an important role in disrupting BBB integrity by prompting IL-8 release.

Keywords: blood–brain barrier; enolase; meningitis; streptococcus suis serotype 2.

PubMed Disclaimer

References

    1. Acta Biochim Pol. 2005;52(2):507-13 - PubMed
    1. Adv Exp Med Biol. 1980;131:69-78 - PubMed
    1. Am J Hematol. 2003 Apr;72(4):234-42 - PubMed
    1. Brain Res. 2002 Feb 15;927(2):153-67 - PubMed
    1. FEBS J. 2011 Apr;278(7):1064-74 - PubMed

Publication types

MeSH terms